Request for Proposals: Grants to Enhance Research Sites in High-burden Countries for Studies of Pregnancy and Preterm Birth

The Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) is now accepting letters of inquiry to identify and develop research sites in low- and middle-income countries as part of a collaborative, multicenter research initiative to investigate causes of and novel strategies for prevention of preterm birth and stillbirth through prospective studies of pregnant women.

This Request for Proposals (RFP) is the second phase of the Preventing Preterm Birth initiative, part of the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health. The objective of this RFP is to identify global health research sites to serve as part of a research network to conduct well-characterized, standardized, prospective studies of pregnant women, conducted in partnership with investigators already funded by the PPB initiative. It is intended that these multi-center investigations will examine the multiple and complex causes of preterm birth in an effort to identify innovative strategies for preterm prevention in low- and middle-income countries.

GAPPS will fund 3-5 existing research sites in low- and middle-income countries with a maximum of USD $1,300,000 each.

Archives

Blogs we follow

MHTF Disclaimer

The posts on this blog do not necessarily reflect the views of the Maternal Health Task Force. Our objective is to provide a platform for our Editorial Committee and other experts to post a myriad of data and evidence, as well as opinions/views that exist in the field which will contribute to expanding the maternal health dialogue.

MATERNAL HEALTH TASK FORCE

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant T76MC00001 and entitled Training Grant in Maternal and Child Health. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.